IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2317 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission


This article has been cited by
1Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Marinella Ruospo,Suetonia C Palmer,Patrizia Natale,Jonathan C Craig,Mariacristina Vecchio,Grahame J Elder,Giovanni FM Strippoli
Cochrane Database of Systematic Reviews.2018;2018(8)
2Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis
Chun-Juan Zhai,Xiao-Wei Yang,Jing Sun,Rong Wang
International Urology and Nephrology.2015;47(3)527
3Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis
Lijuan Zhao,An Liu,Guoshuang Xu
Renal Failure.2021;43(1)1378
4Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis
Stefan Vegter,Keith Tolley,Michael S. Keith,Maarten J. Postma
Value in Health.2011;14(6)852
5The effect of lanthanum carbonate on metabolic acidosis in patients with chronic kidney disease stage IV, V and V-D
William Beaubien-Souligny,Sarah Bezzaoucha,Vincent Pichette,Jean-Philippe Lafrance,Robert Bell,Caroline Lamarche,Denis Ouimet,Michel Vallee
International Urology and Nephrology.2015;47(7)1165
6The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis
Steven Habbous,Sebastian Przech,Rey Acedillo,Sisira Sarma,Amit X. Garg,Janet Martin
Nephrology Dialysis Transplantation.2016;47(7)gfw312
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow